Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
125 participants
OBSERVATIONAL
2014-01-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Urinary Creatinin/Protein Ratio in Preterms
NCT04608279
Non-invasive Objective Assessment of Hemodynamics in Preterm Neonates
NCT04538079
DIAGNOSTIC CONTRIBUTION OF EARLY ABDOMINAL ULTRASOUND IN THE SITUATION OF ACUTE ABDOMEN OF PREMATURE
NCT07275268
Identification of the Risk of Remote Pulmonary Hypertension in Preterm Births.
NCT06800300
Dosage of Serum Tryptase Levels in a Population of Premature Newborns to Evaluate Mast Cell Activity
NCT02787980
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Very preterm babies
Observational model: cohort
Evaluation of the relationship plasma protein levels - neonatal hemodynamics
* Patient inclusion at birth
* Total plasma protein values measurement on cord blood sample at birth
* Hemodynamic evaluation at 6 hours after birth with colour doppler echocardiography and organ blood flow colour doppler
* Total plasma protein and albumin values measurement on plasma sample at 12 hours after birth
* Blood pressure, heart rate, O2 saturation, capillary refill time, rSO2 \[regional (cerebral and somatic) tissue oxygenation by NIRS - near infrared spectroscopy\] will be monitored over 24 hours after birth.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Evaluation of the relationship plasma protein levels - neonatal hemodynamics
* Patient inclusion at birth
* Total plasma protein values measurement on cord blood sample at birth
* Hemodynamic evaluation at 6 hours after birth with colour doppler echocardiography and organ blood flow colour doppler
* Total plasma protein and albumin values measurement on plasma sample at 12 hours after birth
* Blood pressure, heart rate, O2 saturation, capillary refill time, rSO2 \[regional (cerebral and somatic) tissue oxygenation by NIRS - near infrared spectroscopy\] will be monitored over 24 hours after birth.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Birth at less than 32 weeks of gestational age
* Birth in a III level delivery facility at Reunion Island
Exclusion Criteria
1 Minute
1 Hour
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
INSERM CIE1, Dijon, 21000, France
UNKNOWN
Centre Hospitalier Universitaire de la Réunion
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Silvia Iacobelli
Role: PRINCIPAL_INVESTIGATOR
CHU de La Réunion -Site du GHSR
Sylvain Samperiz, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de La Réunion - Hôpital Félix Guyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hopsitalier Universitaire de La Réunion
Saint-Denis, La Réunion, France
Centre Hospitalier de La Réunion
Saint-Pierre, La Réunion, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A00090-45
Identifier Type: OTHER
Identifier Source: secondary_id
2013/CHU/02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.